{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:58:01Z","timestamp":1772135881858,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG088715"],"award-info":[{"award-number":["R21AG088715"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM 061238"],"award-info":[{"award-number":["R01 GM 061238"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R35 GM151985"],"award-info":[{"award-number":["R35 GM151985"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000104","name":"National Aeronautics and Space Administration","doi-asserted-by":"publisher","award":["80NSSC21K0065"],"award-info":[{"award-number":["80NSSC21K0065"]}],"id":[{"id":"10.13039\/100000104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41589-025-01975-4","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T09:02:30Z","timestamp":1752570150000},"page":"1885-1894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A genetically encoded selection for amyloid-\u03b2 oligomer binders"],"prefix":"10.1038","volume":"21","author":[{"given":"ByungUk","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Mannone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7259-7449","authenticated-orcid":false,"given":"Tina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"1975_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Prim. 7, 33 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1975_CR2","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh, Z. & Karaman, R. Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25, 5789 (2020).","journal-title":"Molecules"},{"key":"1975_CR3","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel, H. et al. The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol. Psychiatry 26, 5481\u20135503 (2021).","journal-title":"Mol. Psychiatry"},{"key":"1975_CR4","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","volume":"163","author":"S Muralidar","year":"2020","unstructured":"Muralidar, S., Ambi, S. V., Sekaran, S., Thirumalai, D. & Palaniappan, B. Role of tau protein in Alzheimer\u2019s disease: the prime pathological player. Int. J. Biol. Macromol. 163, 1599\u20131617 (2020).","journal-title":"Int. J. Biol. Macromol."},{"key":"1975_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F. & Dobson, C. M. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu. Rev. Biochem. 86, 27\u201368 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"1975_CR6","doi-asserted-by":"publisher","first-page":"8667","DOI":"10.1039\/C8CC02204F","volume":"54","author":"M T\u00f6rnquist","year":"2018","unstructured":"T\u00f6rnquist, M. et al. Secondary nucleation in amyloid formation. Chem. Commun. 54, 8667\u20138684 (2018).","journal-title":"Chem. Commun."},{"key":"1975_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nsmb.2971","volume":"22","author":"SIA Cohen","year":"2015","unstructured":"Cohen, S. I. A. et al. A molecular chaperone breaks the catalytic cycle that generates toxic A\u03b2 oligomers. Nat. Struct. Mol. Biol. 22, 207\u2013213 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1975_CR8","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1073\/pnas.1218402110","volume":"110","author":"SIA Cohen","year":"2013","unstructured":"Cohen, S. I. A. et al. Proliferation of amyloid-\u03b242 aggregates occurs through a secondary nucleation mechanism. Proc. Natl Acad. Sci. USA 110, 9758\u20139763 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1975_CR9","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.3233\/JAD-179941","volume":"64","author":"EN Cline","year":"2018","unstructured":"Cline, E. N., Bicca, M. A., Viola, K. L. & Klein, W. L. The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade. J. Alzheimers Dis. 64, S567\u2013S610 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"1975_CR10","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","volume":"121","author":"PH Nguyen","year":"2021","unstructured":"Nguyen, P. H. et al. Amyloid oligomers: a joint experimental\/computational perspective on Alzheimer\u2019s disease, Parkinson\u2019s disease, type II diabetes, and amyotrophic lateral sclerosis. Chem. Rev. 121, 2545\u20132647 (2021).","journal-title":"Chem. Rev."},{"key":"1975_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/alzrt226","volume":"5","author":"EY Hayden","year":"2013","unstructured":"Hayden, E. Y. & Teplow, D. B. Amyloid \u03b2-protein oligomers and Alzheimer\u2019s disease. Alzheimers Res. Ther. 5, 60 (2013).","journal-title":"Alzheimers Res. Ther."},{"key":"1975_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41570-021-00254-9","volume":"5","author":"K Kulenkampff","year":"2021","unstructured":"Kulenkampff, K., Wolf Perez, A. M., Sormanni, P., Habchi, J. & Vendruscolo, M. Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases. Nat. Rev. Chem. 5, 277\u2013294 (2021).","journal-title":"Nat. Rev. Chem."},{"key":"1975_CR13","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker, M. & Walker, L. C. Alzheimer\u2019s disease: from immunotherapy to immunoprevention. Cell 186, 4260\u20134270 (2023).","journal-title":"Cell"},{"key":"1975_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova, I., Karran, E. & De Strooper, B. The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat. Neurosci. 15, 349\u2013357 (2012).","journal-title":"Nat. Neurosci."},{"key":"1975_CR15","doi-asserted-by":"publisher","first-page":"e2121966119","DOI":"10.1073\/pnas.2121966119","volume":"119","author":"S Linse","year":"2022","unstructured":"Linse, S., Sormanni, P. & O\u2019connell, D. J. An aggregation inhibitor specific to oligomeric intermediates of A\u03b242 derived from phage display libraries of stable, small proteins. Proc. Natl Acad. Sci. USA 119, e2121966119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1975_CR16","doi-asserted-by":"publisher","first-page":"13509","DOI":"10.1073\/pnas.1919464117","volume":"117","author":"F Aprile","year":"2020","unstructured":"Aprile, F. et al. Rational design of a conformation-specific antibody for the quantification of A\u03b2 oligomers. Proc. Natl Acad. Sci. USA 117, 13509\u201313518 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1975_CR17","doi-asserted-by":"publisher","first-page":"106505","DOI":"10.1016\/j.bpc.2020.106505","volume":"268","author":"EE Cawood","year":"2021","unstructured":"Cawood, E. E., Karamanos, T. K., Wilson, A. J. & Radford, S. E. Visualizing and trapping transient oligomers in amyloid assembly pathways. Biophys. Chem. 268, 106505 (2021).","journal-title":"Biophys. Chem."},{"key":"1975_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1471-4159.2011.07389.x","volume":"119","author":"B O\u2019Nuallain","year":"2011","unstructured":"O\u2019Nuallain, B. et al. A monoclonal antibody against synthetic A\u03b2 dimer assemblies neutralizes brain-derived synaptic plasticity-disrupting A\u03b2. J. Neurochem. 119, 189\u2013201 (2011).","journal-title":"J. Neurochem."},{"key":"1975_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1021\/acscentsci.3c00592","volume":"10","author":"AG Kreutzer","year":"2024","unstructured":"Kreutzer, A. G. et al. Antibodies raised against an A\u03b2 oligomer mimic recognize pathological features in Alzheimer\u2019s disease and associated amyloid-disease brain tissue. ACS Cent. Sci. 10, 104\u2013121 (2024).","journal-title":"ACS Cent. Sci."},{"key":"1975_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06377-8","volume":"7","author":"E Wahlberg","year":"2017","unstructured":"Wahlberg, E. et al. Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-\u03b2. Sci. Rep. 7, 5949 (2017).","journal-title":"Sci. Rep."},{"key":"1975_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuropharm.2016.02.015","volume":"105","author":"T Wang","year":"2016","unstructured":"Wang, T. et al. Naturally occurring autoantibodies against A\u03b2 oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer\u2019s disease than intravenous immunoglobulin. Neuropharmacology 105, 561\u2013576 (2016).","journal-title":"Neuropharmacology"},{"key":"1975_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1471-4159.2001.00592.x","volume":"79","author":"MP Lambert","year":"2001","unstructured":"Lambert, M. P. et al. Vaccination with soluble A\u03b2 oligomers generates toxicity-neutralizing antibodies. J. Neurochem. 79, 595\u2013605 (2001).","journal-title":"J. Neurochem."},{"key":"1975_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neurobiolaging.2008.04.003","volume":"31","author":"PJ Shughrue","year":"2010","unstructured":"Shughrue, P. J. et al. Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons. Neurobiol. Aging 31, 189\u2013202 (2010).","journal-title":"Neurobiol. Aging"},{"key":"1975_CR24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jmb.2008.09.068","volume":"384","author":"A Zameer","year":"2008","unstructured":"Zameer, A., Kasturirangan, S., Emadi, S., Nimmagadda, S. V. & Sierks, M. R. Anti-oligomeric A\u03b2 single-chain variable domain antibody blocks A\u03b2-induced toxicity against human neuroblastoma cells. J. Mol. Biol. 384, 917\u2013928 (2008).","journal-title":"J. Mol. Biol."},{"key":"1975_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"Kayed","year":"2003","unstructured":"Kayed et al. Common structures of soluble amyloid oligomers implies a common mechanism of pathogenesis. Science 300, 486\u2013489 (2003).","journal-title":"Science"},{"key":"1975_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/jnc.14118","volume":"142","author":"A Sebollela","year":"2017","unstructured":"Sebollela, A. et al. A human scFv antibody that targets and neutralizes high molecular weight pathogenic amyloid-\u03b2 oligomers. J. Neurochem. 142, 934\u2013947 (2017).","journal-title":"J. Neurochem."},{"key":"1975_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1089\/hyb.2009.0015","volume":"5","author":"Z Ying","year":"2009","unstructured":"Ying, Z. et al. Preparation and characterization of a monoclonal antibody with high affinity for soluble Ab oligomers. Hybridoma 5, 349\u2013354 (2009).","journal-title":"Hybridoma"},{"key":"1975_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.febslet.2008.12.064","volume":"583","author":"XP Wang","year":"2009","unstructured":"Wang, X. P. et al. Conformation-dependent single-chain variable fragment antibodies specifically recognize \u03b2-amyloid oligomers. FEBS Lett. 583, 579\u2013584 (2009).","journal-title":"FEBS Lett."},{"key":"1975_CR29","doi-asserted-by":"publisher","first-page":"15659","DOI":"10.1073\/pnas.0705888104","volume":"104","author":"AS Gardberg","year":"2007","unstructured":"Gardberg, A. S. et al. Molecular basis for passive immunotherapy of Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 104, 15659\u201315664 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1975_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1471-4159.2006.04157.x","volume":"100","author":"MP Lambert","year":"2007","unstructured":"Lambert, M. P. et al. Monoclonal antibodies that target pathological assemblies of A\u03b2. J. Neurochem. 100, 23\u201335 (2007).","journal-title":"J. Neurochem."},{"key":"1975_CR31","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1074\/jbc.M511018200","volume":"281","author":"EB Lee","year":"2006","unstructured":"Lee, E. B. et al. Targeting amyloid-\u03b2 peptide (A\u03b2) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in A\u03b2 precursor protein (APP) transgenic mice. J. Biol. Chem. 281, 4292\u20134299 (2006).","journal-title":"J. Biol. Chem."},{"key":"1975_CR32","doi-asserted-by":"publisher","first-page":"12503","DOI":"10.1073\/pnas.1206433109","volume":"109","author":"I Morgado","year":"2012","unstructured":"Morgado, I. et al. Molecular basis of \u03b2-amyloid oligomer recognition with a conformational antibody fragment. Proc. Natl Acad. Sci. USA 109, 12503\u201312508 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1975_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1471-4159.2007.04759.x","volume":"103","author":"H Englund","year":"2007","unstructured":"Englund, H. et al. Sensitive ELISA detection of amyloid-\u03b2 protofibrils in biological samples. J. Neurochem. 103, 334\u2013345 (2007).","journal-title":"J. Neurochem."},{"key":"1975_CR34","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1021\/acschemneuro.5b00231","volume":"6","author":"RU Bodani","year":"2015","unstructured":"Bodani, R. U. et al. Antibody against small aggregated peptide specifically recognizes toxic A\u03b2-42 oligomers in Alzheimer\u2019s disease. ACS Chem. Neurosci. 6, 1981\u20131989 (2015).","journal-title":"ACS Chem. Neurosci."},{"key":"1975_CR35","doi-asserted-by":"publisher","first-page":"e90847","DOI":"10.1371\/journal.pone.0090857","volume":"9","author":"K Br\u00e4nnstr\u00f6m","year":"2014","unstructured":"Br\u00e4nnstr\u00f6m, K. et al. A generic method for design of oligomer-specific antibodies. PLoS ONE 9, e90847 (2014).","journal-title":"PLoS ONE"},{"key":"1975_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1073\/pnas.1111232108","volume":"109","author":"JM Perchiacca","year":"2012","unstructured":"Perchiacca, J. M., Reza Ladiwala, A. A., Bhattacharya, M. & Tessier, P. M. Structure-based design of conformation-and sequence-specific antibodies against amyloid \u03b2. Proc. Natl Acad. Sci. USA 109, 84\u201389 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1975_CR37","doi-asserted-by":"publisher","first-page":"e1700488","DOI":"10.1126\/sciadv.1700488","volume":"3","author":"FA Aprile","year":"2017","unstructured":"Aprile, F. A. et al. Selective targeting of primary and secondary nucleation pathways in A\u03b242 aggregation using a rational antibody scanning method. Sci. Adv. 3, e1700488 (2017).","journal-title":"Sci. Adv."},{"key":"1975_CR38","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1039\/C9CS00199A","volume":"49","author":"PC Ke","year":"2020","unstructured":"Ke, P. C. et al. Half a century of amyloids: past, present and future. Chem. Soc. Rev. 49, 5473\u20135509 (2020).","journal-title":"Chem. Soc. Rev."},{"key":"1975_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","volume":"20","author":"L S\u00f6derberg","year":"2023","unstructured":"S\u00f6derberg, L. et al. Lecanemab, aducanumab, and gantenerumab\u2014binding profiles to different forms of amyloid-\u03b2 might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease. Neurotherapeutics 20, 195\u2013206 (2023).","journal-title":"Neurotherapeutics"},{"key":"1975_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","volume":"83","author":"CH van Dyck","year":"2018","unstructured":"van Dyck, C. H. Anti-amyloid-\u03b2 monoclonal antibodies for Alzheimer\u2019s disease: pitfalls and promise. Biol. Psychiatry 83, 311\u2013319 (2018).","journal-title":"Biol. Psychiatry"},{"key":"1975_CR41","doi-asserted-by":"publisher","first-page":"862369","DOI":"10.3389\/fneur.2022.862369","volume":"13","author":"CG Withington","year":"2022","unstructured":"Withington, C. G. & Turner, R. S. Amyloid-related imaging abnormalities with anti-amyloid antibodies for the treatment of dementia due to Alzheimer\u2019s disease. Front. Neurol. 13, 862369 (2022).","journal-title":"Front. Neurol."},{"key":"1975_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/alzrt272","volume":"9","author":"WF Goure","year":"2014","unstructured":"Goure, W. F., Krafft, G. A., Jerecic, J. & Hefti, F. Targeting the proper amyloid-\u03b2 neuronal toxins: a path forward for Alzheimer\u2019s disease immunotherapeutics. Alzheimers Res. Ther. 9, 42 (2014).","journal-title":"Alzheimers Res. Ther."},{"key":"1975_CR43","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1021\/acssynbio.2c00501","volume":"11","author":"BU Lee","year":"2022","unstructured":"Lee, B. U. & Wang, T. A modular scaffold for controlling transcriptional activation via homomeric protein\u2013protein interactions. ACS Synth. Biol. 11, 3198\u20133206 (2022).","journal-title":"ACS Synth. Biol."},{"key":"1975_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/femsre\/fuz026","volume":"44","author":"FD Schramm","year":"2019","unstructured":"Schramm, F. D., Schroeder, K. & Jonas, K. Protein aggregation in bacteria. FEMS Microbiol. Rev. 44, 54\u201372 (2019).","journal-title":"FEMS Microbiol. Rev."},{"key":"1975_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.tibtech.2006.02.007","volume":"24","author":"S Ventura","year":"2006","unstructured":"Ventura, S. & Villaverde, A. Protein quality in bacterial inclusion bodies. Trends Biotechnol. 24, 179\u2013185 (2006).","journal-title":"Trends Biotechnol."},{"key":"1975_CR46","doi-asserted-by":"crossref","unstructured":"Villar-Piqu\u00e9, A. & Ventura, S. Inclusion bodies in the study of amyloid aggregation. In Protein Aggregation in Bacteria: Functional and Structural Properties of Inclusion Bodies in Bacterial (eds Doglia, S. M. & Lotti, M.) (Wiley, 2014).","DOI":"10.1002\/9781118845363.ch4"},{"key":"1975_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12419","volume":"7","author":"P Misra","year":"2016","unstructured":"Misra, P., Kodali, R., Chemuru, S., Kar, K. & Wetzel, R. Rapid \u03b1-oligomer formation mediated by the A\u03b2 C terminus initiates an amyloid assembly pathway. Nat. Commun. 7, 12419 (2016).","journal-title":"Nat. Commun."},{"key":"1975_CR48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/cbic.201000602","volume":"12","author":"M Dasari","year":"2011","unstructured":"Dasari, M. et al. Bacterial inclusion bodies of Alzheimer\u2019s disease \u03b2-amyloid peptides can be employed to study native-like aggregation intermediate states. ChemBioChem 12, 407\u2013423 (2011).","journal-title":"ChemBioChem"},{"key":"1975_CR49","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jmb.2005.02.030","volume":"347","author":"M Carri\u00f3","year":"2005","unstructured":"Carri\u00f3, M., Gonz\u00e1lez-Montalb\u00e1n, N., Vera, A., Villaverde, A. & Ventura, S. Amyloid-like properties of bacterial inclusion bodies. J. Mol. Biol. 347, 1025\u20131037 (2005).","journal-title":"J. Mol. Biol."},{"key":"1975_CR50","doi-asserted-by":"publisher","first-page":"eaax5108","DOI":"10.1126\/sciadv.aax5108","volume":"5","author":"DC Delivoria","year":"2019","unstructured":"Delivoria, D. C. et al. Bacterial production and direct functional screening of expanded molecular libraries for discovering inhibitors of protein aggregation. Sci. Adv. 5, eaax5108 (2019).","journal-title":"Sci. Adv."},{"key":"1975_CR51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nchembio.1988","volume":"12","author":"JC Saunders","year":"2016","unstructured":"Saunders, J. C. et al. An in vivo platform for identifying inhibitors of protein aggregation. Nat. Chem. Biol. 12, 94\u2013101 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"1975_CR52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/pro.33","volume":"18","author":"LL Lee","year":"2009","unstructured":"Lee, L. L., Ha, H., Chang, Y. T. & Delisa, M. P. Discovery of amyloid-\u03b2 aggregation inhibitors using an engineered assay for intracellular protein folding and solubility. Protein Sci. 18, 277\u2013286 (2009).","journal-title":"Protein Sci."},{"key":"1975_CR53","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0022-2836(02)00399-6","volume":"319","author":"C Wurth","year":"2002","unstructured":"Wurth, C., Guimard, N. K. & Hecht, M. H. Mutations that reduce aggregation of the Alzheimer\u2019s A\u03b242 peptide: an unbiased search for the sequence determinants of A\u03b2 amyloidogenesis. J. Mol. Biol. 319, 1279\u20131290 (2002).","journal-title":"J. Mol. Biol."},{"key":"1975_CR54","doi-asserted-by":"publisher","first-page":"19232","DOI":"10.1073\/pnas.0703793104","volume":"104","author":"G Habicht","year":"2007","unstructured":"Habicht, G. et al. Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing A\u03b2 protofibrils. Proc. Natl Acad. Sci. USA 104, 19232\u201319237 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1975_CR55","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.molimm.2008.09.008","volume":"46","author":"P Lafaye","year":"2009","unstructured":"Lafaye, P., Achour, I., England, P., Duyckaerts, C. & Rougeon, F. Single-domain antibodies recognize selectively small oligomeric forms of amyloid \u03b2, prevent A\u03b2-induced neurotoxicity and inhibit fibril formation. Mol. Immunol. 46, 695\u2013704 (2009).","journal-title":"Mol. Immunol."},{"key":"1975_CR56","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jmb.2010.10.059","volume":"405","author":"C Haupt","year":"2011","unstructured":"Haupt, C. et al. Amyloid fibril recognition with the conformational B10 antibody fragment depends on electrostatic interactions. J. Mol. Biol. 405, 341\u2013348 (2011).","journal-title":"J. Mol. Biol."},{"key":"1975_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13195-023-01361-z","volume":"16","author":"A Bigi","year":"2024","unstructured":"Bigi, A. et al. A single-domain antibody detects and neutralises toxic A\u03b242 oligomers in the Alzheimer\u2019s disease CSF. Alzheimers Res Ther. 16, 13 (2024).","journal-title":"Alzheimers Res Ther."},{"key":"1975_CR58","doi-asserted-by":"publisher","first-page":"24765","DOI":"10.1074\/jbc.M111.329763","volume":"287","author":"ARA Ladiwala","year":"2012","unstructured":"Ladiwala, A. R. A. et al. Conformational differences between two amyloid \u03b2 oligomers of similar size and dissimilar toxicity. J. Biol. Chem. 287, 24765\u201324773 (2012).","journal-title":"J. Biol. Chem."},{"key":"1975_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jfma.2015.08.004","volume":"115","author":"YF Shea","year":"2016","unstructured":"Shea, Y. F. et al. A systematic review of familial Alzheimer\u2019s disease: differences in presentation of clinical features among three mutated genes and potential ethnic differences. J. Formos. Med. Assoc. 115, 67\u201375 (2016).","journal-title":"J. Formos. Med. Assoc."},{"key":"1975_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.63364","volume":"10","author":"M Seuma","year":"2021","unstructured":"Seuma, M., Faure, A., Badia, M., Lehner, B. & Bolognesi, B. The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer\u2019s disease mutations. eLife 10, 1\u201349 (2021).","journal-title":"eLife"},{"key":"1975_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34742-3","volume":"13","author":"M Seuma","year":"2022","unstructured":"Seuma, M., Lehner, B. & Bolognesi, B. An atlas of amyloid aggregation: the impact of substitutions, insertions, deletions and truncations on amyloid \u03b2 fibril nucleation. Nat. Commun. 13, 7084 (2022).","journal-title":"Nat. Commun."},{"key":"1975_CR62","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1021\/acschemneuro.4c00120","volume":"15","author":"A Carlsson","year":"2024","unstructured":"Carlsson, A., Axell, E., Emanuelsson, C., Olsson, U. & Linse, S. The ability of DNAJB6b to suppress amyloid formation depends on the chaperone aggregation state. ACS Chem. Neurosci. 15, 1732\u20131737 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"1975_CR63","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1074\/jbc.REV118.002809","volume":"294","author":"M Haslbeck","year":"2019","unstructured":"Haslbeck, M., Weinkauf, S. & Buchner, J. Small heat shock proteins: simplicity meets complexity. J. Biol. Chem. 294, 2121\u20132132 (2019).","journal-title":"J. Biol. Chem."},{"key":"1975_CR64","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fgene.2017.00058","volume":"8","author":"EP Barykin","year":"2017","unstructured":"Barykin, E. P., Mitkevich, V. A., Kozin, S. A. & Makarov, A. A. Amyloid \u03b2 modification: a key to the sporadic Alzheimer\u2019s disease? Front. Genet. 8, 58 (2017).","journal-title":"Front. Genet."},{"key":"1975_CR65","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2147\/CIA.S325026","volume":"17","author":"M Vaz","year":"2022","unstructured":"Vaz, M., Silva, V., Monteiro, C. & Silvestre, S. Role of aducanumab in the treatment of Alzheimer\u2019s disease: challenges and opportunities. Clin. Interv. Aging 17, 797\u2013810 (2022).","journal-title":"Clin. Interv. Aging"},{"key":"1975_CR66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1975_CR67","doi-asserted-by":"publisher","first-page":"105317","DOI":"10.1016\/j.jbc.2023.105317","volume":"299","author":"N \u00d6sterlund","year":"2023","unstructured":"\u00d6sterlund, N. et al. The C-terminal domain of the antiamyloid chaperone DNAJB6 binds to amyloid-\u03b2 peptide fibrils and inhibits secondary nucleation. J. Biol. Chem. 299, 105317 (2023).","journal-title":"J. Biol. Chem."},{"key":"1975_CR68","doi-asserted-by":"publisher","first-page":"e2206240119","DOI":"10.1073\/pnas.2206240119","volume":"119","author":"KA Murray","year":"2022","unstructured":"Murray, K. A. et al. De novo designed protein inhibitors of amyloid aggregation and seeding. Proc. Natl Acad. Sci. USA 119, e2206240119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1975_CR69","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1073\/pnas.0711731105","volume":"105","author":"W Hoyer","year":"2008","unstructured":"Hoyer, W. et al. Stabilization of a \u03b2-hairpin in monomeric Alzheimer\u2019s amyloid-\u03b2 peptide inhibits amyloid formation. Proc. Natl Acad. Sci. USA 105, 5099\u20135104 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1975_CR70","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"1975_CR71","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nprot.2016.010","volume":"11","author":"G Meisl","year":"2016","unstructured":"Meisl, G. et al. Molecular mechanisms of protein aggregation from global fitting of kinetic models. Nat. Protoc. 11, 252\u2013272 (2016).","journal-title":"Nat. Protoc."},{"key":"1975_CR72","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nmeth.3515","volume":"12","author":"B Hubbard","year":"2015","unstructured":"Hubbard, B. et al. Continuous directed evolution of DNA-binding proteins to improve TALEN specificity. Nat. Methods 12, 939\u2013942 (2015).","journal-title":"Nat. Methods"},{"key":"1975_CR73","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1128\/JB.180.8.2063-2071.1998","volume":"180","author":"KC Murphy","year":"1998","unstructured":"Murphy, K. C. et al. Use of bacteriophage \u03bb recombination functions to promote gene replacement in Escherichia coli. J. Bacteriol. 180, 2063\u20132071 (1998).","journal-title":"J. Bacteriol."},{"key":"1975_CR74","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/978-1-0716-0524-0_38","volume":"2141","author":"S Linse","year":"2020","unstructured":"Linse, S. Expression and purification of intrinsically disordered A\u03b2 peptide and setup of reproducible aggregation kinetics experiment. Methods Mol. Biol. 2141, 731\u2013754 (2020).","journal-title":"Methods Mol. Biol."},{"key":"1975_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45192-4","volume":"15","author":"R Kumar","year":"2024","unstructured":"Kumar, R. et al. Identification of potential aggregation hotspots on A\u03b242 fibrils blocked by the anti-amyloid chaperone-like BRICHOS domain. Nat. Commun. 15, 965 (2024).","journal-title":"Nat. Commun."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-025-01975-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-025-01975-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-025-01975-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T04:02:15Z","timestamp":1763956935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-025-01975-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":75,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1975"],"URL":"https:\/\/doi.org\/10.1038\/s41589-025-01975-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.11.642651","asserted-by":"object"}]},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"29 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A provisional patent application (application no. 63\/657,564) on the cCadC\u2013A\u03b242 method for detecting oligomer binders has been filed by the University of Wisconsin, with B.L. and T.W. as coinventors. The other author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}